Collectively, the results presented here demonstrate a role of SPRYD7 in CRC progression and metastasis, highlighting its role as an inductor of angiogenesis, which makes this protein an interesting protein to be explored as a therapeutic target for the treatment of CRC patients. Here, SPRYD7 is linked to colorectal carcinoma.